D 95 Pill - yellow six-sided, 12mm
Pill with imprint D 95 is Yellow, Six-sided and has been identified as Lamotrigine 150 mg. It is supplied by Aurobindo Pharma.
Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D 95
Lamotrigine
- Imprint
- D 95
- Strength
- 150 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Six-sided
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
povidone k30,
sodium starch glycolate type A potato,
magnesium stearate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0229 | Aurobindo Pharma Limited |
| 16714-0702 | NorthStar Rx LLC |
Related images for "D 95"
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,808)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal CD, Lamictal ODT
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.